vs
Tarsus Pharmaceuticals, Inc.（TARS）与WSFS FINANCIAL CORP（WSFS）财务数据对比。点击上方公司名可切换其他公司
WSFS FINANCIAL CORP的季度营收约是Tarsus Pharmaceuticals, Inc.的1.8倍（$275.3M vs $151.7M），WSFS FINANCIAL CORP净利率更高（31.5% vs -5.5%，领先37.0%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 7.5%），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 1.7%）
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
WSFS金融集团是一家金融服务企业，核心子公司WSFS银行是总部位于特拉华州及大特拉华谷地区规模最大、经营历史最久的本地管理银行与财富管理机构。集团共运营115个网点，其中88个为银行网点，分布在宾夕法尼亚、特拉华、新泽西、佛罗里达、弗吉尼亚、内华达六州，提供全面金融服务。
TARS vs WSFS — 直观对比
营收规模更大
WSFS
是对方的1.8倍
$151.7M
营收增速更快
TARS
高出120.9%
7.5%
净利率更高
WSFS
高出37.0%
-5.5%
两年增速更快
TARS
近两年复合增速
1.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $151.7M | $275.3M |
| 净利润 | $-8.4M | $86.8M |
| 毛利率 | — | — |
| 营业利润率 | -5.3% | — |
| 净利率 | -5.5% | 31.5% |
| 营收同比 | 128.4% | 7.5% |
| 净利润同比 | 63.8% | 31.7% |
| 每股收益（稀释后） | $-0.17 | $1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TARSWSFS
| Q1 26 | — | $275.3M | ||
| Q4 25 | $151.7M | $271.9M | ||
| Q3 25 | $118.7M | $270.5M | ||
| Q2 25 | $102.7M | $267.5M | ||
| Q1 25 | $78.3M | $256.1M | ||
| Q4 24 | $66.4M | $261.5M | ||
| Q3 24 | $48.1M | $267.7M | ||
| Q2 24 | $40.8M | $266.0M |
净利润TARSWSFS
| Q1 26 | — | $86.8M | ||
| Q4 25 | $-8.4M | $72.7M | ||
| Q3 25 | $-12.6M | $76.4M | ||
| Q2 25 | $-20.3M | $72.3M | ||
| Q1 25 | $-25.1M | $65.9M | ||
| Q4 24 | $-23.1M | $64.2M | ||
| Q3 24 | $-23.4M | $64.4M | ||
| Q2 24 | $-33.3M | $69.3M |
营业利润率TARSWSFS
| Q1 26 | — | — | ||
| Q4 25 | -5.3% | 35.8% | ||
| Q3 25 | -12.2% | 37.3% | ||
| Q2 25 | -21.6% | 35.7% | ||
| Q1 25 | -33.5% | 34.0% | ||
| Q4 24 | -36.8% | 32.3% | ||
| Q3 24 | -52.3% | 31.9% | ||
| Q2 24 | -81.6% | 34.0% |
净利率TARSWSFS
| Q1 26 | — | 31.5% | ||
| Q4 25 | -5.5% | 26.7% | ||
| Q3 25 | -10.6% | 28.3% | ||
| Q2 25 | -19.8% | 27.0% | ||
| Q1 25 | -32.1% | 25.7% | ||
| Q4 24 | -34.8% | 24.6% | ||
| Q3 24 | -48.7% | 24.1% | ||
| Q2 24 | -81.6% | 26.0% |
每股收益（稀释后）TARSWSFS
| Q1 26 | — | $1.64 | ||
| Q4 25 | $-0.17 | $1.33 | ||
| Q3 25 | $-0.30 | $1.37 | ||
| Q2 25 | $-0.48 | $1.27 | ||
| Q1 25 | $-0.64 | $1.12 | ||
| Q4 24 | $-0.57 | $1.08 | ||
| Q3 24 | $-0.61 | $1.08 | ||
| Q2 24 | $-0.88 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $417.3M | — |
| 总债务越低越好 | $72.4M | — |
| 股东权益账面价值 | $343.4M | $2.7B |
| 总资产 | $562.2M | $22.1B |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资TARSWSFS
| Q1 26 | — | — | ||
| Q4 25 | $417.3M | $1.7B | ||
| Q3 25 | $401.8M | — | ||
| Q2 25 | $381.1M | — | ||
| Q1 25 | $407.9M | — | ||
| Q4 24 | $291.4M | $1.2B | ||
| Q3 24 | $317.0M | — | ||
| Q2 24 | $323.6M | — |
总债务TARSWSFS
| Q1 26 | — | — | ||
| Q4 25 | $72.4M | — | ||
| Q3 25 | $72.3M | — | ||
| Q2 25 | $72.1M | — | ||
| Q1 25 | $72.0M | — | ||
| Q4 24 | $71.8M | — | ||
| Q3 24 | $71.7M | — | ||
| Q2 24 | $71.6M | — |
股东权益TARSWSFS
| Q1 26 | — | $2.7B | ||
| Q4 25 | $343.4M | $2.7B | ||
| Q3 25 | $335.1M | $2.8B | ||
| Q2 25 | $332.6M | $2.7B | ||
| Q1 25 | $342.5M | $2.7B | ||
| Q4 24 | $224.5M | $2.6B | ||
| Q3 24 | $237.5M | $2.7B | ||
| Q2 24 | $252.2M | $2.5B |
总资产TARSWSFS
| Q1 26 | — | $22.1B | ||
| Q4 25 | $562.2M | $21.3B | ||
| Q3 25 | $534.6M | $20.8B | ||
| Q2 25 | $495.0M | $20.8B | ||
| Q1 25 | $500.8M | $20.5B | ||
| Q4 24 | $377.0M | $20.8B | ||
| Q3 24 | $376.3M | $20.9B | ||
| Q2 24 | $376.8M | $20.7B |
负债/权益比TARSWSFS
| Q1 26 | — | — | ||
| Q4 25 | 0.21× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.3M | — |
| 自由现金流经营现金流 - 资本支出 | $13.0M | — |
| 自由现金流率自由现金流/营收 | 8.6% | — |
| 资本支出强度资本支出/营收 | 4.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-22.3M | — |
8季度趋势，按日历期对齐
经营现金流TARSWSFS
| Q1 26 | — | — | ||
| Q4 25 | $19.3M | $220.0M | ||
| Q3 25 | $18.3M | $121.5M | ||
| Q2 25 | $-29.4M | $37.2M | ||
| Q1 25 | $-20.7M | $8.7M | ||
| Q4 24 | $-22.2M | $219.9M | ||
| Q3 24 | $-8.7M | $3.1M | ||
| Q2 24 | $-14.4M | $44.8M |
自由现金流TARSWSFS
| Q1 26 | — | — | ||
| Q4 25 | $13.0M | $213.6M | ||
| Q3 25 | $16.3M | $120.3M | ||
| Q2 25 | $-30.4M | $35.2M | ||
| Q1 25 | $-21.2M | $6.3M | ||
| Q4 24 | $-22.3M | $205.6M | ||
| Q3 24 | $-8.9M | $-489.0K | ||
| Q2 24 | $-15.4M | $42.1M |
自由现金流率TARSWSFS
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 78.6% | ||
| Q3 25 | 13.8% | 44.5% | ||
| Q2 25 | -29.6% | 13.2% | ||
| Q1 25 | -27.1% | 2.5% | ||
| Q4 24 | -33.5% | 78.6% | ||
| Q3 24 | -18.6% | -0.2% | ||
| Q2 24 | -37.8% | 15.8% |
资本支出强度TARSWSFS
| Q1 26 | — | — | ||
| Q4 25 | 4.2% | 2.3% | ||
| Q3 25 | 1.6% | 0.5% | ||
| Q2 25 | 1.0% | 0.7% | ||
| Q1 25 | 0.8% | 0.9% | ||
| Q4 24 | 0.1% | 5.5% | ||
| Q3 24 | 0.6% | 1.4% | ||
| Q2 24 | 2.5% | 1.0% |
现金转化率TARSWSFS
| Q1 26 | — | — | ||
| Q4 25 | — | 3.03× | ||
| Q3 25 | — | 1.59× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 3.43× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
